| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.052 | 0.4 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |